Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

JW Pharmaceutical reports desfesoterodine derivatives

Oct. 10, 2016

Toray Industries prepares and tests agents for urinary incontinence

Oct. 6, 2016

FDA grants orphan drug designation to AbbVie's atrasentan

Oct. 5, 2016

Dimerix reports positive safety data for phase II trial of DMX-200

Oct. 5, 2016

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Bayer and Evotec establish 5-year research partnership in kidney disease

Sep. 22, 2016

Promising phase II topline results for sparsentan in focal segmental glomerulosclerosis

Sep. 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...